Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orexo announces launch of Abstral in Japan


Thursday, 12 Dec 2013 03:30am EST 

Orexo AB:Says Kyowa Hakko Kirin Co., Ltd (KHK) has commenced the launch of Abstral in Japan.Says Abstral will be jointly distributed by KHK and Hisamitsu Pharmaceutical Co.Says Orexo will receive a single digit royalty on net sales of Abstral in Japan.Says the manufacturing and marketing approval of Abstral in Japan was received on Sept. 20, 2013. 

Company Quote

126.25
2.25 +1.81%
5:58am EDT